Thoracoscopic thoracic duct sealing with LigaSure in two children with refractory postoperative chylothorax

Karim Khelif1, Fadi Maassarani, Martine Dassonville

  • 1Department of Pediatric Surgery, Queen Fabiola Children's University Hospital, Brussels, Belgium. karim.khelif@huderf.be

Insights

This study shows thoracoscopic thoracic duct thermofusion and section using the LigaSure device is a safe and effective treatment for persistent chylothorax in children after cardiac surgery.

Area of Science:

  • Pediatric Cardiac Surgery
  • Thoracic Surgery
  • Minimally Invasive Procedures

Background:

  • Chylothorax is a rare but serious complication following pediatric cardiac surgery.
  • Persistent chylothorax requires effective management to prevent complications like malnutrition and infection.

Observation:

  • Two pediatric patients developed refractory chylothorax post-cardiac surgery.
  • Conventional medical management failed to resolve the chylous drainage.

Findings:

  • Thoracoscopic thoracic duct thermofusion and section using the LigaSure device was successfully performed in both cases.
  • Lymph leakage ceased rapidly, with no recurrence at one-year follow-up.

Implications:

  • This technique offers a simple, effective, and safe option for managing pediatric postoperative chylothorax.
  • LigaSure device demonstrates utility beyond its intended vascular sealing for lymphatic procedures.
Abstract